Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV

BACKGROUND: Rosuvastatin is a lipid-lowering agent widely prescribed in people living with HIV, which is actively transported into the liver, making it a potential victim of drug–drug interactions with antiretroviral agents. OBJECTIVES: The aims of this study were to characterise the pharmacokinetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Courlet, Perrine, Guidi, Monia, Alves Saldanha, Susana, Stader, Felix, Traytel, Anna, Cavassini, Matthias, Stoeckle, Marcel, Buclin, Thierry, Marzolini, Catia, Decosterd, Laurent A., Csajka, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932937/
https://www.ncbi.nlm.nih.gov/pubmed/33124006
http://dx.doi.org/10.1007/s40262-020-00946-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932937/
https://www.ncbi.nlm.nih.gov/pubmed/33124006
http://dx.doi.org/10.1007/s40262-020-00946-3

Ejemplares similares